atopic asthma characterized chronic inflammation bronchial mucosa immunoglobulin e mechanisms believed prominent specific proeosinophilic mediators interleukin essential cofactors ige switching play pivotal role asthma exact role individual inflammatory mediators play development disease humans unknown using semiquantitative reverse chain reaction amplification bronchial biopsies NUMBER atopic asthmatics tested hypothesis mrna expression relative mrna correlates validated indicators disease severity mrna copies relative mrna detected bronchial biopsies atopic asthmatics numbers mrna copies relative mrna correlated disease severity assessed aas asthma score r NUMBER p NUMBER baseline fev1 r p NUMBER baseline peak expiratory flow rate r p NUMBER peak expiratory flow rate variability NUMBER wk r NUMBER p NUMBER histamine pc20 r p NUMBER conversely numbers mrna copies relative mrna did correlate asthma severity positively correlated total serum ige concentrations r p NUMBER present results support concept determine asthma clinical expression severity inference support development targeted therapies eosinophil ige dependent il NUMBER b lymphocytes il NUMBER transcriptase polymerase il NUMBER il NUMBER beta actin il NUMBER il NUMBER beta actin il NUMBER beta actin NUMBER NUMBER NUMBER il NUMBER beta actin NUMBER il NUMBER il NUMBER